SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma gets nod to incorporate wholly owned subsidiary

11 Jul 2026 Evaluate

Mankind Pharma has received approval for the incorporation of a wholly owned subsidiary (WOS) company in Netherlands to act as a Special Purpose Vehicle for holding investments in R&D assets and business development activities focused on treatment of niche therapies. The Board of Directors of the company at its meeting held on July 11, 2026, has inter-alia, considered and approved the same. 

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. 


Mankind Pharma Share Price

2557.10 13.05 (0.51%)
23-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1954.05
Dr. Reddys Labs. 1166.50
Cipla 1393.75
Lupin 2396.00
Zydus Lifesciences 1113.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: